In last trading session, SILO Pharma Inc (NASDAQ:SILO) saw 3.61 million shares changing hands with its beta currently measuring 1.62. Company’s recent per share price level of $0.6 trading at $0.03 or 4.42% at ring of the bell on the day assigns it a market valuation of $4.32M. That closing price of SILO’s stock is at a discount of -650.0% from its 52-week high price of $4.50 and is indicating a premium of 31.67% from its 52-week low price of $0.41. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.35 million shares which gives us an average trading volume of 1.03 million if we extend that period to 3-months.
SILO Pharma Inc (NASDAQ:SILO) trade information
Upright in the green during last session for gaining 4.42%, in the last five days SILO remained trading in the red while hitting it’s week-highest on Wednesday, 07/16/25 when the stock touched $0.6 price level, adding 16.67% to its value on the day. SILO Pharma Inc’s shares saw a change of -40.58% in year-to-date performance and have moved -3.21% in past 5-day. SILO Pharma Inc (NASDAQ:SILO) showed a performance of 2.16% in past 30-days. Number of shares sold short was 0.8 million shares which calculate 0.35 days to cover the short interests.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 11.18% during past 5 years.
SILO Pharma Inc (NASDAQ:SILO)’s Major holders
Insiders are in possession of 9.50% of company’s total shares while institution are holding 3.45 percent of that, with stock having share float percentage of 3.81%. Investors also watch the number of corporate investors in a company very closely, which is 3.45% institutions for SILO Pharma Inc that are currently holding shares of the company. VIRTU FINANCIAL LLC is the top institutional holder at SILO for having 41848.0 shares of worth $41000.0. And as of 2024-06-30, it was holding 1.3709 of the company’s outstanding shares.
The second largest institutional holder is FINANCIAL ADVOCATES INVESTMENT MANAGEMENT, which was holding about 23938.0 shares on 2024-06-30. The number of shares represents firm’s hold over 0.7842 of outstanding shares, having a total worth of $23938.0.
On the other hand, AdvisorShares Trust-AdvisorShares Psychedelics ETF and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of May 31, 2025 , the former fund manager was holding 164.24 shares of worth $98558.0 or 0.17% of the total outstanding shares. The later fund manager was in possession of 25.66 shares on May 31, 2025 , making its stake of worth around $15395.0 in the company or a holder of 0.03% of company’s stock.
